Boston Scientific Corp (NYSE:BSX)
| 55.89 Delayed Data As of Nov 30 |  +0.45 / +0.81%Today’s Change | 44.26 Today|||52-Week Range 55.95 | +20.79% Year-to-Date |
Latest BSX News | Press Releases
| PBH or BSX: Which Is the Better Value Stock Right Now? Nov 29 / Zacks.com - Paid Partner Content | Boston Scientific (BSX) Closes the Relievant Medsystems Buyout Nov 21 / Zacks.com - Paid Partner Content |
| Could Ozempic Harm These 3 Medical Device Stocks? Nov 25 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 55.44 |
| Today’s open | 55.46 |
| Day’s range | 54.94 - 55.95 |
| Volume | 8,346,178 |
| Average volume (3 months) | 8,021,869 |
| Market cap | $81.5B |
Data as of 4:00pm ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | -35.19% |
| Earnings growth (this year) | +14.41% |
| Earnings growth (next 5 years) | +12.10% |
| Revenue growth (last year) | +6.68% |
| P/E ratio | 68.2 |
| Price/Sales | 5.25 |
| Price/Book | 4.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | -0.09 | -0.04% |
| DXCMDexcom Inc | -0.66 | -0.57% |
| WSTWest Pharmaceutical ... | +0.06 | +0.02% |
| ZBHZimmer Biomet Holdin... | +0.03 | +0.03% |
Data as of 4:00pm ET, 11/30/2023
Financials
| Next reporting date | January 31, 2024 |
| EPS forecast (this quarter) | $0.52 |
| Annual revenue (last year) | $12.7B |
| Annual profit (last year) | $698.0M |
| Net profit margin | 5.50% |
Profile
Sector Distribution Services |
Industry Medical Distributors |
No executives to display |
Corporate headquarters Marlborough, Massachusetts |
Forecasts
